Zobrazeno 1 - 10
of 35
pro vyhledávání: ''
Pharmacologic Cardioversion in Patients with Paroxysmal Atrial Fibrillation: A Network Meta-Analysis
Autor:
Konstantinos Gatzoulis, Ioannis Doundoulakis, Konstantinos Tsioufis, Athanasios Kordalis, Spyridon Deftereos, Christodoulos Stefanadis, Dimitris Tsiachris, Eirini Pagkalidou
Publikováno v:
Cardiovascular Drugs and Therapy. 35:293-308
We sought to indirectly compare and rank antiarrhythmic agents focusing exclusively on adults with paroxysmal atrial fibrillation in order to identify the most effective for pharmacologic cardioversion over different time settings (4 h as primary, an
Autor:
Alessandro Minati, Mizar D'Abramo, Fabio Miraldi, Sara Saltarocchi, Francesco Cardetta, Omar Giacinto, Mario Lusini, Massimo Chello
Publikováno v:
Cardiovascular Drugs and Therapy.
Purpose Post-pericardiotomy syndrome (PPS) is a common complication of cardiac surgery. This systematic review aimed to investigate the efficacy of colchicine, indomethacin, and dexamethasone in the treatment and prophylaxis of PPS. Methods Literatur
Autor:
Raffaele De Caterina, João Morais
Publikováno v:
Cardiovascular Drugs and Therapy
Atrial fibrillation (AF) is a common heart rhythm disturbance; its incidence increases with age, and it is also an independent risk factor for stroke. Anticoagulation has been proven as the most effective way to reduce the risk of stroke in patients
Autor:
Seiji Takashima, Masanori Asakura, Yasuhiko Sakata, Shoji Sanada, Koichi Node, Tsunehiko Kuzuya, Michihiko Tada, Hiroshi Asanuma, Yoshiro Shinozaki, Masatsugu Hori, Hidezo Mori, Masafumi Kitakaze
Publikováno v:
Cardiovascular Drugs and Therapy. 15:225-231
Amlodipine increases NO levels in coronary vessels and aorta via bradykinin-dependent mechanisms in vitro. We have previously reported that a long-acting Ca channel blocker, benidipine, increases cardiac NO levels in ischemic canine hearts, suggestin
Autor:
Christian Hamm, J. Thormann, Matthias Straub, Aleksandra Miskovic, Veselin Mitrovic, Heinz F. Pitschner
Publikováno v:
Cardiovascular Drugs and Therapy. 14:511-521
Clinical drawbacks of beta-blocker treatment in stable angina have motivated researchers to provide alternative heart-rate-lowering agents, such as tedisamil, which additionally exerts antiischemic and antiarrhythmic effects by blockade of cellular r
Publikováno v:
Cardiovascular Drugs and Therapy. 14:23-29
Vascular ATP-dependent potassium (K+ATP) channels open and contribute to reactive hyperemia (RH) in animals. The contribution of K+ATP channels to ischemic vasolidation during RH and interactions with endothelium-derived nitric oxide have not been we
Publikováno v:
Cardiovascular Drugs and Therapy, 22, 4, pp. 257-9
Cardiovascular Drugs and Therapy, 22, 257-9
Cardiovascular Drugs and Therapy, 22, 257-9
As caffeine is one of the most widely consumed pharmacologically active compounds in the world, its possible association with cardiovascular disease has been the subject of scientific study for decades. Disappointingly, results from epidemiological s
Publikováno v:
Cardiovascular Drugs and Therapy. 10:159-166
We evaluated the electrophysiological mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline in seven patients, pilsicainide in two, and disopyramide in two, and procainamide in three) in the induction of orthodromic atrioventricu
Publikováno v:
Cardiovascular Drugs and Therapy. 10:125-136
The purpose of this study was to elucidate the role of activation of the alpha 1-adrenergic signal transduction pathway and of protein kinase C (PKC) in the mechanism of protection of functional recovery by ischemic preconditioning in the isolated pe
Publikováno v:
Cardiovascular Drugs and Therapy. 8:761-768
Digoxin and other low doses of drugs that have inotropic properties may have an important role to play in the therapy of patients with chronic heart failure. There is convincing evidence that digoxin is effective in relieving the signs and symptoms o